Category: antiviral drug

9 Things You Need to Know About Paxlovid

Do you know when Paxlovid should be used to treat COVID-19? Are you aware of the reasons for the mixed results of its phase 2 and phase 3 clinical trial data versus its real-life studies? Do you know what the most significant concern about Paxlovid is for its future application in treating COVID-19? Reputed as…


A Deep Dive Into Oral Antiviral Pills for COVID (Part 1)

As the world figures out how to coexist with COVID-19, the introduction of oral pills looks promising, in addition to the treatments of monoclonal antibodies and remdesivir. In this multiple series of articles, we will review three oral antivirals against COVID: Paxlovid developed by Pfizer, molnupiravir developed by Merck, and Azvudine developed by Genuine Biotech…


US to Buy Siga’s IV Drug Worth $26 Million to Fight Monkeypox Outbreak

The U.S. government will buy Siga Technologies Inc.’s $26-million worth of intravenous formulation of antiviral drug Tpoxx, the company said on Tuesday. The company plans to deliver by next year the order for the IV treatment, which would be a vital option for patients unable to swallow the oral pill as monkeypox symptoms include rashes…


Denmark Approves Merck’s COVID-19 Antiviral Treatment in EU First

Denmark on Thursday approved an antiviral COVID-19 drug produced by Merck and Ridgeback Biotherapeutics for at-risk patients with symptoms, including the elderly. The Scandinavian country became the first in the European Union to approve the antiviral treatment called molnupiravir. The pill is still under review by the European Medicines Agency (EMA). “We are recommending the pill…